Deep Tech Startups

Airamp develops a patented control plane software for AI infrastructure that optimizes network routing in GPU datacenters. The software uses physics-inspired predictive algorithms to eliminate network bottlenecks and maximize data throughput for large AI training and inference workloads.

1 investor

Airhart Aeronautics designs and builds advanced personal airplanes with a focus on safety, reliability, and intuitive operation. The company serves individuals and operators seeking easier-to-fly, safer aircraft with modern avionics and human-centered design.

1 investor

ESA BIC (Business Incubation Centre) is a startup incubation programme run by AZO across sites in Bavaria, Northern Germany, and North Rhine-Westphalia, supporting entrepreneurs building space-related and deeptech companies in fields such as robotics, mobility, aerospace, and AI. It offers financing, mentoring, R&D support, and market-entry help, along with access to space technologies and technical facilities.

1 investor

Airphrame captures and provides aerial and remote sensing data to help organizations digitally map and analyze the physical world as it changes. Founded in 2012 with agriculture-focused remote sensing products, it now offers a broader solution where customers can obtain aerial data without operating equipment themselves.

1 investor

AirSafe builds an onboard Detect-And-Avoid (DAA) system for drones that identifies cooperative and non-cooperative air traffic using audio AI, vision AI, ADS-B transponders, and live FPV stream analysis. The system replaces ground-based human observers to enable Beyond Visual Line of Sight (BVLOS) drone operations and support regulatory authorizations.

1 investor

AIRSENSE develops gas sensor devices combining chemical expertise and data analytics to detect, identify, and assess airborne substances in near real time. Its product portfolio serves applications such as CBRNE (chemical, biological, radiological, nuclear, and explosive) detection.

1 investor

Airzy develops biocatalyst-enhanced systems that accelerate CO₂ capture and removal across industrial, ocean-based, and direct air capture applications. The company's technology reduces energy requirements and capital costs while enabling permanent carbon storage through mineral carbonation.

1 investor

Ajaya Bio develops bispecific therapies designed to eliminate disease-driving cells while sparing healthy ones, using its BOLT-360 discovery platform built around hybrid binders, precise activation, and advanced linkers. The company operates in the biotherapeutics field.

1 investor

Akari Therapeutics is an oncology biotechnology company developing antibody drug conjugates (ADCs) built on a proprietary PH1 spliceosome-modulating payload that disrupts RNA splicing in cancer cells. Its pipeline includes AKTX-101, targeting the Trop2 receptor, and AKTX-102, targeting CEACAM5 across solid tumors.

1 investor

Akimbo Technologies builds an intrusion-tolerant cybersecurity system based on its patented Fault-Tolerant Distributed Computing (FTDC), branded DEFENSA, which detects and corrects cyberattacks in real time on mission-critical operating systems without a cloud connection. Its primary market is the defense industry, particularly military marine vessels and combat vehicles, with secondary markets in commercial shipping, port authorities and autonomous vehicles.

1 investor

Akin designs and builds frontier AI models and AI-powered solutions used by public and private organisations, drawing on neuroscience and chaos theory. The company aims to develop personal AI systems.

1 investor

Alacrity operates not-for-profit programs, international investment funds, and accelerators that support technology entrepreneurship, mentoring young business leaders to build new companies with local and international resources. Its ecosystem includes Alacrity Canada, the Alacrity Foundation UK, and the L-SPARK accelerator for Canadian technology startups.

1 investor

Alchemedicine is a drug discovery company focused on research and development of new small-molecule medicines, using its proprietary synthesis technology HiSAP® to improve on existing drugs' weak efficacy, side effects, and pharmacokinetics. It pursues multiple simultaneous R&D programs across disease areas with high unmet medical need.

1 investor

Alén Space designs, manufactures, and operates small satellites, offering end-to-end mission services along with communication platforms, subsystems, and components. It serves space agencies, companies, educational institutions, and high-tech centres for satellite constellations and single small satellite projects.

1 investor

Alephium is a scalable Layer-1 blockchain that pairs energy-efficient Proof-of-Work security with expressive smart contracts, using a BlockFlow sharding design and a stateful UTXO model. It targets developers building dApps, smart contracts, and tokens as well as everyday Web3 users.

1 investor

This is the personal website of Alex Gajewski, a cofounder of Pantograph, an independent research lab building general-purpose robots; it shares his background and essays on robotics, compute markets, and deep learning. It is not a company site but a personal page listing his roles and technical ideas.

1 investor

Alia Mentis is an independent research hub that develops proprietary advanced materials and manufacturing processes, handling everything from research and co-design through prototyping and industrial validation. Its technologies serve demanding sectors including aerospace, automotive, motorsport, and sports and protective equipment.

1 investor

Aliena develops Hall thruster electric propulsion systems for nanosatellites, microsatellites, and small-to-medium satellite platforms, spanning 100 W to 1.35 kW power classes. The company operates a jet propulsion test and production facility in Singapore and works with space agencies and satellite operators.

1 investor

The Alignment Research Center (ARC) is a non-profit research organization working on aligning future machine learning systems with human interests. Its current focus is developing theoretical methods to predict and explain neural network behavior through mechanistic analysis of a network's weights.

1 investor

AAA builds a radio-frequency sensor mesh that captures millimeter-accurate, high-rate ground-truth motion data for robotics, working without line of sight in dust, darkness, or reflective environments. Its data is used to train reinforcement-learning policies, calibrate and validate systems, and deploy robots in industrial "physical AI" applications.

1 investor

Alloplex Biotherapeutics develops a non-engineered autologous cellular therapy for cancer, built on its ENLYST immune cell training platform and lead candidate SUPLEXA, which trains a patient's peripheral blood cells ex vivo to create anti-tumor therapeutic cells. The company operates in the immuno-oncology and cell therapy space and has completed a Phase 1 clinical trial across multiple tumor types.

1 investor

ALLOX develops an AI-enabled platform that uses high-throughput genomics and machine learning to discover biophysical parameters governing protein function for drug discovery. The company focuses on identifying allosteric drug targets to enable development of therapies for previously undruggable proteins.

1 investor

All Seeing Tech develops radio frequency (RF) hardware supporting a 225MHz to 2600MHz frequency range with up to 8MHz instantaneous bandwidth, customizable wideband and narrowband waveforms for voice, video, and data, and MIMO transmit/receive capability. The product supports multi-unit wireless synchronization for RADAR and communications applications.

1 investor

Alltrna develops engineered, chemically modified tRNA oligonucleotides as programmable medicines, using proprietary machine learning tools to design tRNA molecules with desired pharmacologic properties. Its initial therapeutic focus is treating nonsense mutations by reading through premature termination codons to restore full-length protein production, addressing a category it calls Stop Codon Disease.

1 investor